ClearHormones Editorial Team

Articles by ClearHormones Editorial Team

• Perimenopause Heart Palpitations: Causes, Patterns, and When to Seek Care

  Heart palpitations during perimenopause are common but unsettling. Estrogen fluctuations, autonomic shifts, and overlapping triggers explain most episodes — here is what the research shows and how clinicians evaluate them.

• HRT After Breast Cancer: Key Considerations for Symptom Management

  HRT after breast cancer raises difficult questions for survivors managing menopause symptoms. This guide reviews the current evidence base, non-hormonal alternatives, and frameworks survivors use when discussing care with oncology and menopause clinicians.

• Menopause Dry Skin and Collagen Loss: Causes, Evidence, Options

  Menopause dry skin and collagen loss accelerate sharply in the first five postmenopausal years — women lose roughly 30% of skin collagen. Here's what current evidence shows about why, and which interventions have data.

• Hair Thinning in Women: Hormonal Causes and Evidence-Based Options

  A clinician-reviewed explainer on hormonal hair thinning in women — androgenetic alopecia, menopause shedding, thyroid links, PCOS, telehealth providers, costs, and red flags.

• Hormonal IUD in Perimenopause: Contraception, Bleeding & HRT Use

  A hormonal IUD in perimenopause does three things at once: prevents pregnancy (still possible until 12 months amenorrhea), reduces heavy bleeding by up to 90%, and provides endometrial protection if you add estrogen. Here's what the evidence shows.

• Hot Flashes Treatment: Evidence-Based Options for Menopause and Night Sweats

  A clinician-reviewed look at hot flashes treatment — from hormone therapy and the new neurokinin-3 antagonists to lifestyle changes, telehealth access, and cost. Discuss any approach with a qualified clinician.

• How to Choose a Menopause Telehealth Provider: An Editorial Buyer's Guide

  How to choose menopause telehealth comes down to seven factors: clinician credentials, state coverage, prescribing scope, lab handling, insurance model, communication cadence, and price transparency. This editorial guide walks through each.

• Compounded vs FDA HRT: Evidence, Safety, and Cost Comparison

  Compounded vs FDA HRT differ in regulation, evidence base, dosing accuracy, and out-of-pocket cost. Here is what current guidelines from NAMS, ACOG, and the FDA say — and how telehealth menopause clinics typically prescribe.

• Estradiol Patch vs Pill: How Transdermal and Oral HRT Compare

  Estradiol patch vs pill — transdermal delivery bypasses first-pass liver metabolism and carries a lower venous thromboembolism signal, while oral estradiol is cheaper and well-studied. Here is how the two compare on efficacy, safety, and cost.

• Estrogen Osteoporosis Prevention: Evidence, Timing, and Bone Health Options

  Estrogen withdrawal at menopause triggers rapid bone loss. Here's what the evidence shows about estrogen osteoporosis prevention, the timing hypothesis, alternatives, and how to weigh options with a clinician.

• Hormonal Migraines in Perimenopause: Causes, Triggers, and Options

  Hormonal migraines frequently intensify during perimenopause as estradiol levels swing unpredictably. Here's what current evidence shows about estrogen withdrawal, aura risk, and the options worth discussing with a clinician.

• HRT Blood Clots Risk: What the Evidence Shows About VTE and Hormone Therapy

  The HRT blood clots risk varies sharply by route, formulation, age, and personal history. Transdermal estradiol shows little to no extra venous thromboembolism risk in large database studies, while oral formulations roughly double it from a low baseline.